These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 416322

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availability.
    Schade DS, Eaton RP.
    Diabetes; 1975 Nov; 24(11):1020-6. PubMed ID: 1183732
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
    Tiengo A, Muggeo M, Assan R, Fedele D, Crepaldi G.
    Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus.
    Calvert GD, Blight L, Franklin J, Oliver J, Wise P, Gallus AS.
    Eur J Clin Pharmacol; 1980 May; 17(5):355-62. PubMed ID: 6998709
    [No Abstract] [Full Text] [Related]

  • 10. Insulin receptors on monocytes from patients with ketosis-prone diabetes mellitus.
    Pedersen O, Beck-Nielsen H, Heding L.
    Diabetes; 1978 Nov; 27(11):1098-104. PubMed ID: 102554
    [No Abstract] [Full Text] [Related]

  • 11. Dose response to insulin in man: differential effects on glucose and ketone body regulation.
    Schade DS, Eaton RP.
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1038-53. PubMed ID: 874043
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased glucose disappearance rate after short-term clofibrate administration in normal subjects and in patients with chemical diabetes.
    Ferrari C, Testori GP, Bertazzoni A, Romussi M, Caldara R, Frezzati S.
    Horm Metab Res; 1978 Jan; 10(1):4-6. PubMed ID: 631736
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis.
    Burge MR, Garcia N, Qualls CR, Schade DS.
    Metabolism; 2001 Feb; 50(2):171-7. PubMed ID: 11229425
    [Abstract] [Full Text] [Related]

  • 16. The regulation of plasma ketone body concentration by counterregulatory hormones in man.
    Schade DS, Eaton RP.
    Diabetes; 1977 Oct; 26(10):989-96. PubMed ID: 908465
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.
    Gerich JE, Lorenzi M, Bier DM, Schneider V, Tsalikian E, Karam JH, Forsham PH.
    N Engl J Med; 1975 May 08; 292(19):985-9. PubMed ID: 804137
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical characterization of ketosis-resistant young diabetics of northern India. In vivo effects of i.v. glucose, s.c. epinephrine and i.v. glucagon and in vitro effects of anti-insulin serum on adipose tissue lipolysis.
    Krishna Ram B, Sachdev G, Chopra A, Karmarkar MG.
    Acta Diabetol Lat; 1984 May 08; 21(2):141-51. PubMed ID: 6433609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.